Gottlieb, the FDA and dumbing down medicine

Southwest Journal of Pulmonary and Critical Care

Robbins RA¹ 

[1] Phoenix Pulmonary and Critical Care Research and Education Foundation, Gilbert, AZ USA;

关键词: Gottlieb;    FDA;    Federal Drug Administration;    pharmaceutical;    drug;    approval;    opioid;    prescribing;    authority;    nurse practitioner;   

DOI  :  10.13175/swjpcc047-17

来源: DOAJ

【 摘 要 】

No abstract available. Article truncated at 150 words. In the last few weeks several events have occurred that might impact drug approval in the US. President Donald Trump's pick for FDA commissioner, Dr. Scott Gottlieb. Gottlieb, like many of Trump’s picks for administration healthcare positions, is a physician. He also has experience as deputy FDA commissioner from 2005-7.However, his confirmation hearing before the Senate Committee on Health, Education, Labor and Pensions alarmed some who say his deep ties to the pharmaceutical industry will cause a conflict of interest (1). Others praised Gottlieb as the right man to lead the FDA. As opposed to Trump, Gottlieb denied any connection between vaccines and autism (1,2). Dr. Gottlieb called the issue "one of the most exhaustively studied questions in medical history," before saying, "There is no plausible link between vaccines and autism. At some point, we have to accept 'no' for an answer." However, Gottlieb did not give a straight …

【 授权许可】

Unknown